| Erythromycin | ACTIVE INGREDIENT | 63937KV33D | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| Erythromycin | ACTIVE MOIETY | 63937KV33D | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| Ammonia | INACTIVE INGREDIENT | 5138Q19F1X | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| croscarmellose sodium | INACTIVE INGREDIENT | M28OL1HH48 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| crospovidone | INACTIVE INGREDIENT | 68401960MK | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| diacetylated monoglycerides | INACTIVE INGREDIENT | 5Z17386USF | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| hydroxypropyl cellulose (type H) | INACTIVE INGREDIENT | RFW2ET671P | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| hypromellose phthalate (24% phthalate, 55 CST) | INACTIVE INGREDIENT | 87Y6436BKR | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| povidones | INACTIVE INGREDIENT | FZ989GH94E | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| sodium citrate | INACTIVE INGREDIENT | 1Q73Q2JULR | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| sorbitan monooleate | INACTIVE INGREDIENT | 06XEA2VD56 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| talc | INACTIVE INGREDIENT | 7SEV7J4R1U | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| Erythromycin | ACTIVE INGREDIENT | 63937KV33D | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| Erythromycin | ACTIVE MOIETY | 63937KV33D | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| Ammonia | INACTIVE INGREDIENT | 5138Q19F1X | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| croscarmellose sodium | INACTIVE INGREDIENT | M28OL1HH48 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| crospovidone | INACTIVE INGREDIENT | 68401960MK | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| diacetylated monoglycerides | INACTIVE INGREDIENT | 5Z17386USF | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| hydroxypropyl cellulose (type H) | INACTIVE INGREDIENT | RFW2ET671P | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| hypromellose phthalate (24% PHTHALATE, 55 CST) | INACTIVE INGREDIENT | 87Y6436BKR | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| povidones | INACTIVE INGREDIENT | FZ989GH94E | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| sodium citrate | INACTIVE INGREDIENT | 1Q73Q2JULR | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| sorbitan monooleate | INACTIVE INGREDIENT | 06XEA2VD56 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| talc | INACTIVE INGREDIENT | 7SEV7J4R1U | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| ERYTHROMYCIN | ACTIVE INGREDIENT | 63937KV33D | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| ERYTHROMYCIN | ACTIVE MOIETY | 63937KV33D | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| DIACETYLATED MONOGLYCERIDES | INACTIVE INGREDIENT | 5Z17386USF | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| HYDROXYPROPYL CELLULOSE | INACTIVE INGREDIENT | RFW2ET671P | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST) | INACTIVE INGREDIENT | 87Y6436BKR | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| SORBITAN MONOOLEATE | INACTIVE INGREDIENT | 06XEA2VD56 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| Erythromycin | ACTIVE INGREDIENT | 63937KV33D | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| Erythromycin | ACTIVE MOIETY | 63937KV33D | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| AMMONIA | INACTIVE INGREDIENT | 5138Q19F1X | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| DIACETYLATED MONOGLYCERIDES | INACTIVE INGREDIENT | 5Z17386USF | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST) | INACTIVE INGREDIENT | 87Y6436BKR | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| SORBITAN MONOOLEATE | INACTIVE INGREDIENT | 06XEA2VD56 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| ERYTHROMYCIN | ACTIVE INGREDIENT | 63937KV33D | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| Erythromycin | ACTIVE INGREDIENT | 63937KV33D | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| Erythromycin | ACTIVE MOIETY | 63937KV33D | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| ERYTHROMYCIN | ACTIVE MOIETY | 63937KV33D | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| croscarmellose sodium | INACTIVE INGREDIENT | M28OL1HH48 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| crospovidone | INACTIVE INGREDIENT | 68401960MK | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| diacetylated monoglycerides | INACTIVE INGREDIENT | 5Z17386USF | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| DIACETYLATED MONOGLYCERIDES | INACTIVE INGREDIENT | 5Z17386USF | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| hydroxypropyl cellulose | INACTIVE INGREDIENT | RFW2ET671P | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| HYDROXYPROPYL CELLULOSE | INACTIVE INGREDIENT | RFW2ET671P | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| hypromellose phthalate (24% phthalate, 55 CST) | INACTIVE INGREDIENT | 87Y6436BKR | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST) | INACTIVE INGREDIENT | 87Y6436BKR | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| povidone | INACTIVE INGREDIENT | FZ989GH94E | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| sodium citrate | INACTIVE INGREDIENT | 1Q73Q2JULR | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| sorbitan monooleate | INACTIVE INGREDIENT | 06XEA2VD56 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| SORBITAN MONOOLEATE | INACTIVE INGREDIENT | 06XEA2VD56 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| talc | INACTIVE INGREDIENT | 7SEV7J4R1U | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [STAT RX USA LLC] | 1 | |